Maria A. Streltsova,Anastasia I. Palamarchuk,Julia D. Vavilova,Maria O. Ustiuzhanina,Anna A. Boyko,R. A. Velichinskii,Nadezhda A. Alekseeva,М. В. Гречихина,Olga A. Shustova,Alexander M. Sapozhnikov,Elena I. Kovalenko
The growing attention to NK cells for cancer cell therapy is associated with the need to establish highly efficient protocols for their genetic modification, particularly by retroviral transduction.